JENS HANSSON, CHAIRMAN OF THE BOARD
Jens has two decades of experience from private equity and venture capital investments. He is an engineer by trade and has prior to his career within the finance industry acted in leading industrial positions and as CEO for a publicly traded company. Jens currently acts as partner at private equity firm Dedicap AB. Jens has a M.Sc. in electrical engineering from Chalmers,
Gothenburg and a B.Sc. in economics from the Gothenburg School of Economics
ESKIL SÖDERLIND, BOARD MEMBER
Eskil has more than 25 years of business experience in life sciences and has been instrumental in the incorporation of more than 10 different companies. Eskil has an established network of contacts in the MedTech industry crucial for the project. Eskil has a PhD in molecular biology from Uppsala and holds an MBA-diploma. Eskil is a co-founder of Colzyx.
ANN-CHRISTIN MALMBORG HAGER, BOARD MEMBER
Anki has more than 20 years of experience in starting life science companies. Previous experience includes CEO of PainDrainer AB, SenzaGen AB, DiaProst AB, Cantargia AB and XImmune AB. Anki has also worked as Investment Director at LU Bioscience AB and VP Business Development at Alligator Bioscience AB. Currently she works as CEO of Uptake Bio AB. Anki has a M.Sc. in chemical engineering and a PhD in Immunotechnology.
GÖRAN CONRADSSON, BOARD MEMBER
Göran has more than 40 years of experience in life science. Previous experience includes founder and CEO of Ziccum AB. He has run his own consulting firm for international business development for 15 years mainly for startup companies with innovative products in MedTech and bioanalysis. Göran has also worked as marketing and sales manager for Pharmacia Biotech AB in Germany. Göran has a M.Sc. in chemistry engineering from the Royal Institute of Technology, Stockholm.
INGRID ATTERYD HEIMAN, BOARD MEMBER
Ingrid has extensive management and board experience from the food industry, pharmaceuticals, biomedicine, life science, women's health, and financial services, as well as experience as a board member and chairman of the board from several listed Life Science companies. Ingrid has been involved in streamlining, strategy development, mergers, acquisitions, and IPOs. She holds a M.Sc. in Finance and Industrial Marketing from Lund University and an MBA in International Business from Uppsala University.